Literature DB >> 26362780

Mildly elevated serum total bilirubin levels are negatively associated with carotid atherosclerosis among elderly persons with type 2 diabetes.

Ryuichi Kawamoto1,2, Daisuke Ninomiya1,2, Yoichi Hasegawa1,2, Yoshihisa Kasai2, Tomo Kusunoki2, Nobuyuki Ohtsuka2, Teru Kumagi1, Masanori Abe1.   

Abstract

Diabetes is strongly associated with several mechanisms of tissue damage such as oxidative stress. Serum bilirubin may have a beneficial role in preventing oxidative changes in cardiovascular disease (CVD). Limited information is available on whether serum bilirubin is an independent confounding factor for carotid atherosclerosis among elderly persons with type 2 diabetes. The study subjects were 169 men aged 79 ± 8 (mean ± SD) years and 205 women aged 81 ± 8 years that were enrolled consecutively from patients in the medical department. Carotid intima-media thickness (IMT) and plaque were derived via B-mode ultrasonography. Multiple linear regression analysis showed that serum total bilirubin (β = -0.160) was significantly associated with carotid IMT. Compared to subjects with a serum total bilirubin of tertile-1 (0.13-0.58 mg/dL), the multivariate-adjusted odds ratio (95% confidence interval) of carotid IMT ≥1.0 mm including plaque and carotid plaque was 0.46 (0.23-0.93) and 0.32 (0.17-0.60) in the Tertile-3 group (0.87-1.93 mg/dL), respectively. Next, data were further stratified by gender, age, smoking status, medication and prevalence of CVD. There were no significant differences in serum total bilirubin levels between selected subgroups. Our data demonstrated a negative association between serum total bilirubin and carotid atherosclerosis among elderly persons with type 2 diabetes.

Entities:  

Keywords:  Atherosclerosis; Serum total bilirubin; carotid artery; confounding factor; type 2 diabetes; ultrasonography

Mesh:

Substances:

Year:  2015        PMID: 26362780     DOI: 10.3109/10641963.2015.1060990

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 1064-1963            Impact factor:   1.749


  12 in total

1.  Association Between Bilirubin, Atazanavir, and Cardiovascular Disease Events Among People Living With HIV Across the United States.

Authors:  Heidi M Crane; Robin M Nance; Susan R Heckbert; Corey Ritchings; Lisa Rosenblatt; Matthew Budoff; Brian R Wood; David L Tirschwell; H Nina Kim; William C Mathews; Elvin Geng; Richard D Moore; Peter W Hunt; Joseph J Eron; Greer A Burkholder; Daniel R Drozd; Felicia C Chow; Kyra J Becker; Joseph R Zunt; Emily L Ho; Rizwan Kalani; Andrew Huffer; Bridget M Whitney; Michael S Saag; Mari M Kitahata; Joseph A C Delaney
Journal:  J Acquir Immune Defic Syndr       Date:  2019-08-15       Impact factor: 3.731

2.  Inverse Association between Serum Bilirubin Levels and Retinopathy in Patients with Type 2 Diabetes Mellitus.

Authors:  Divya Karuppannasamy; Raghuram Venkatesan; Lekha Thankappan; Raghuram Andavar; Sundar Devisundaram
Journal:  J Clin Diagn Res       Date:  2017-02-01

3.  Association Between Serum Bilirubin and the Progression of Carotid Atherosclerosis in Type 2 Diabetes.

Authors:  Inkuk Lee; Hyeok-Hee Lee; Yongin Cho; Young Ju Choi; Byung Wook Huh; Byung-Wan Lee; Eun Seok Kang; Seok Won Park; Bong-Soo Cha; Eun Jig Lee; Yong-Ho Lee; Kap Bum Huh
Journal:  J Lipid Atheroscler       Date:  2020-01-13

Review 4.  Bilirubin as a metabolic hormone: the physiological relevance of low levels.

Authors:  Justin F Creeden; Darren M Gordon; David E Stec; Terry D Hinds
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-12-07       Impact factor: 4.310

5.  Effect of bilirubin concentration on the risk of diabetic complications: A meta-analysis of epidemiologic studies.

Authors:  Bo Zhu; Xiaomei Wu; Yifei Bi; Yang Yang
Journal:  Sci Rep       Date:  2017-01-30       Impact factor: 4.379

6.  Mildly elevated serum total bilirubin is negatively associated with hemoglobin A1c independently of confounding factors among community-dwelling middle-aged and elderly persons.

Authors:  Ryuichi Kawamoto; Daisuke Ninomiya; Kensuke Senzaki; Teru Kumagi
Journal:  J Circ Biomark       Date:  2017-08-18

7.  Differential impact of serum total bilirubin level on cerebral atherosclerosis and cerebral small vessel disease.

Authors:  Jonguk Kim; Seung-Jae Yoon; Min-Hee Woo; Sang-Heum Kim; Nam-Keun Kim; Jinkwon Kim; Ok-Joon Kim; Seung-Hun Oh
Journal:  PLoS One       Date:  2017-03-20       Impact factor: 3.240

Review 8.  Serum bilirubin and ischaemic stroke: a review of literature.

Authors:  Xiao Wang; Danhong Wu; Ping Zhong
Journal:  Stroke Vasc Neurol       Date:  2020-03-05

9.  The U-Shaped Association between Bilirubin and Diabetic Retinopathy Risk: A Five-Year Cohort Based on 5323 Male Diabetic Patients.

Authors:  Miao Liu; Jianhua Wang; Yao He
Journal:  J Diabetes Res       Date:  2018-10-30       Impact factor: 4.011

10.  The Impact of Health Resort Treatment on the Nonenzymatic Endogenous Antioxidant System.

Authors:  Jadwiga Kuciel-Lewandowska; Michał Kasperczak; Bożena Bogut; Roman Heider; Wojciech T Laber; Wojciech Laber; Małgorzata Paprocka-Borowicz
Journal:  Oxid Med Cell Longev       Date:  2020-01-31       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.